Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
Have you EVER DISCUSSED the possibility of getting a genetic test for cancer risk with a doctor or other health professional?
[NUMERATOR AND DENOMINATOR:]
What kind of cancer did your father have?
What kind of cancer did your mother have?
Was your biological mother under 50 years of age when [cancer type] was first diagnosed?
What kinds of cancer did your brother/brothers have?
What kind of cancer did your sister/sisters have?
Was your sister under 50 years of age when [cancer type] was first diagnosed?
How many of these sisters were under 50 years of age when [cancer type] was first diagnosed?
What kinds of cancer did your son/sons have?
What kinds of cancer did your daughter/daughters have?
Was your daughter under 50 years of age when [cancer type] was first diagnosed?
How many of these daughters were under 50 years of age when [cancer type] was first diagnosed?
The United States Preventive Services Task Force (USPSTF) issued an evidence-based statement in 2005 recommending that women whose family history is associated with an increased risk for deleterious mutations in BRCA1 or BRCA2 genes be referred for genetic counseling and evaluation for BRCA testing. Specific family history patterns identified by the USPSTF as associated with an increased risk for deleterious mutations in the BRCA1 and BRCA2 genes in non-Ashkenazi Jewish women include:
2 first-degree relatives with breast cancer, 1 of whom received the diagnosis at age 50 years or younger;
a combination of 3 or more first- or second-degree relatives with breast cancer regardless of age at diagnosis;
a combination of both breast and ovarian cancer among first- and second-degree relatives;
a first-degree relative with bilateral breast cancer;
a combination of 2 or more first- or second-degree relatives with ovarian cancer regardless of age at diagnosis;
a first- or second-degree relative with both breast and ovarian cancer at any age; and
a history of breast cancer in a male relative.
NHIS does not ascertain:
1) Ashkenazi Jewish ancestry: analyses assume non-Ashkenazi Jewish ancestry;
2) cancer history for second-degree relatives: only first-degree relatives are included in the analyses; and
3) bilateral breast cancer: this USPSTF increased risk family history category is excluded from the analyses.
This Indicator uses Age-Adjustment Groups:
Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.
In 2013, the original baseline was revised from 23.3 to 34.6 due to a change in methodology that affects how missing and unknown survey responses are handled. The target was adjusted from 25.6 to 38.1 to reflect the revised baseline using the original target-setting method.
Additional resources about the objective.
This hyperlink will direct you to a non-governmental Website or application.
The appearance of external hyperlinks does not constitute endorsement by the United
States Department of Health & Human Services (HHS) of the hyperlinked Website
or application, or the information, products or services contained therein. Such
hyperlinks are provided consistent with the intended purpose of this HHS Website.
Visitors to the hyperlinked Website or application will be subject to the Website
or application's privacy policies. These practices may be different than those of
this HHS Website.
You will be redirected to: link